Cortico-basal ganglia and cortico-cerebellar circuits in Parkinson's disease: Pathophysiology or compensation?

Behavioral Neuroscience

Volumn 127, Issue 2, 2013, Pages 222-236

  Martinu, Kristina ^a,b   Monchi, Oury ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE DE RECHERCHE   (Canada)

Author keywords

Cerebellum; Compensation; Levodopa; Parkinson's disease; Striatum

Indexed keywords

ACETYLCHOLINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; HISTAMINE; LEVODOPA; NORADRENALIN; SEROTONIN;

ARTICLE; BASAL GANGLION; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN METABOLISM; CEREBELLUM CORTEX; COGNITIVE DEFECT; DOPAMINERGIC NERVE CELL; DYSKINESIA; HUMAN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NERVE PROJECTION; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; VENTRAL TEGMENTUM; WISCONSIN CARD SORTING TEST;

BASAL GANGLIA; CEREBELLUM; CEREBRAL CORTEX; HUMANS; NEURAL PATHWAYS; PARKINSON DISEASE;

EID: 84876066644     PISSN: 07357044     EISSN: 19390084     Source Type: Journal    
DOI: 10.1037/a0031226     Document Type: Article

References (164)

1. Albin, R. L., Young, A. B., & Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. Trends in Neurosciences, 12, 366-375.
2. Alder, R., & Barbas, H. (1995). Complementary distribution of the phosphoproteins DARPP-32 and I-1 in the cerebellar system. Neuroreport, 6, 2368-2372.
3. Alexander, G. E., Crutcher, M. D., & DeLong, M. R. (1991). Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Progress in Brain Research, 85, 119-146.
4. Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
5. Appel-Cresswell, S., de la Fuente-Fernandez, R., Galley, S., & McKeown, M. J. (2010). Imaging of compensatory mechanisms in Parkinson's disease. Current Opinion in Neurology, 23, 407-412.
6. Asanuma, C., Thach, W. T., & Jones, E. G. (1983). Distribution of cerebellar terminations and their relation to other afferent terminations in the ventral lateral thalamic region of the monkey. Brain Research, 286, 237-265.
7. Asanuma, K., Tang, C., Ma, Y., Dhawan, V., Mattis, P., Edwards, C.,... Eidelberg, D. (2006). Network modulation in the treatment of Parkinson's disease. Brain: A Journal of Neurology, 129, 2667-2678.
8. Ballanger, B., Baraduc, P., Broussolle, E., Le Bars, D., Desmurget, M., & Thobois, S. (2008). Motor urgency is mediated by the contralateral cerebellum in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 79, 1110-1116.
9. Barik, S., & de Beaurepaire, R. (1996). Evidence for a functional role of the dopamine D3 receptors in the cerebellum. Brain Research, 737, 347-350.
10. Benecke, R., Rothwell, J. C., Dick, J. P., Day, B. L., & Marsden, C. D. (1987). Disturbance of sequential movements in patients with Parkinson's disease. Brain: A Journal of Neurology, 110, 361-379.
11. Benninger, D. H., Thees, S., Kollias, S. S., Bassetti, C. L., & Waldvogel, D. (2009). Morphological differences in Parkinson's disease with and without rest tremor. Journal of Neurology, 256, 256-263.
12. Bergman, H., Wichmann, T., Karmon, B., & DeLong, M. R. (1994). The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. Journal of Neurophysiology, 72, 507-520.
13. Bezard, E., Brotchie, J. M., & Gross, C. E. (2001). Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies. Nature Reviews Neuroscience, 2, 577-588.
14. Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston,K. J....Brooks, D. J. (1998). Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H2 15O PET. Journal of Neurophysiology, 79, 1070-1080.
15. Boecker, H., Jankowski, J., Ditter, P., & Scheef, L. (2008). A role of the basal ganglia and midbrain nuclei for initiation of motor sequences. NeuroImage, 39, 1356-1369.
16. Bostan, A. C., Dum, R. P., & Strick, P. L. (2010). The basal ganglia communicate with the cerebellum. PNAS: Proceedings of the National Academy of Sciences of the United States of America, 107, 8452-8456.
17. Bostan, A. C., & Strick, P. L. (2010). The cerebellum and basal ganglia are interconnected. Neuropsychology Review, 20, 261-270.
18. Bouthenet, M. L., Souil, E., Martres, M. P., Sokoloff, P., Giros, B., & Schwartz, J. C. (1991). Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA. Brain Research, 564, 203-219.
19. Brooks, D. J., Piccini, P., Turjanski, N., & Samuel, M. (2000). Neuroimaging of dyskinesia. Annals of Neurology, 47, S154-S159.
20. Brusa, L., Ceravolo, R., Kiferle, L., Monteleone, F., Iani, C., Schillaci, O.,...Koch, G. (2012). Metabolic changes induced by theta burst stimulation of the cerebellum in dyskinetic Parkinson's disease patients. Parkinsonism & Related Disorders, 18, 59-62.
21. Brusa, L., Versace, V., Koch, G., Iani, C., Stanzione, P., Bernardi, G., & Centonze, D. (2006). Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease. Clinical Neurophysiology, 117, 1917-1921.
22. Buhmann, C., Glauche, V., Sturenburg, H. J., Oechsner, M., Weiller, C., & Buchel, C. (2003). Pharmacologically modulated fMRI: Cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain: A Journal of Neurology, 126, 451-461.
23. Clower, D. M., West, R. A., Lynch, J. C., & Strick, P. L. (2001). The inferior parietal lobule is the target of output from the superior colliculus, hippocampus, and cerebellum. The Journal of Neuroscience, 21, 6283-6291.
24. Cools, R., Stefanova, E., Barker, R. A., Robbins, T. W., & Owen, A. M. (2002). Dopaminergic modulation of high-level cognition in Parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain: A Journal of Neurology, 125, 584-594.
25. Cooper, I. S. (1956). Neurosurgical alleviation of parkinsonism. The American Surgeon, 22, 1070-1075.
26. Cooper, J. A., Sagar, H. J., Doherty, S. M., Jordan, N., Tidswell, P., & Sullivan, E. V. (1992). Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain: A Journal of Neurology, 115, 1701-1725.
27. Cunnington, R., Windischberger, C., Deecke, L., & Moser, E. (2002). The preparation and execution of self-initiated and externally-triggered movement: A study of event-related fMRI. NeuroImage, 15, 373-385.
28. Debaere, F., Wenderoth, N., Sunaert, S., Van Hecke, P., & Swinnen, S. P. (2003). Internal vs. external generation of movements: Differential neural pathways involved in bimanual coordination performed in the presence or absence of augmented visual feedback. NeuroImage, 19, 764-776.
29. DeLong, M. R., & Wichmann, T. (2007). Circuits and circuit disorders of the basal ganglia. Archives of Neurology, 64, 20-24.
30. Deuschl, G., Raethjen, J., Baron, R., Lindemann, M., Wilms, H., & Krack, P. (2000). The pathophysiology of Parkinsonian tremor: A review. Journal of Neurology, 247, V33-V48.
31. Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schafer, H., Botzel, K.,...Voges, J. (2006). A randomized trial of deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine, 355, 896-908.
32. Doyon, J., Bellec, P., Amsel, R., Penhune, V., Monchi, O., Carrier, J.,...Benali, H. (2009). Contributions of the basal ganglia and functionally related brain structures to motor learning. Behavioural Brain Research, 199, 61-75.
33. Doyon, J., Benali, H. (2005). Reorganization and plasticity in the adult brain during learning of motor skills. Current Opinion in Neurobiology, 15, 161-167.
34. Doyon, J., Penhune, V., & Ungerleider, L. G. (2003). Distinct contribution of the cortico-striatal and cortico-cerebellar systems to motor skill learning. Neuropsychologia, 41, 252-262.
35. Doyon, J., & Ungerleider, L. (2002). Functional anatomy of motor skill learning. In: L. Squire & D. Schacter, (Eds.), Neuropsychology of memory (pp. 225-238). New York, NY: Guilford Press.
36. Dum, R. P., & Strick, P. L. (2003). An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex. Journal of Neurophysiology, 89, 634-639.
37. Durif, F. (1999). Treating and preventing levodopa-induced dyskinesias: Current and future strategies. Drugs & Aging, 14, 337-345.
38. Eidelberg, D. (2009). Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends in Neurosciences, 32, 548-557.
39. Eidelberg, D., Moeller, J. R., Dhawan, V., Spetsieris, P., Takikawa, S., Ishikawa, T.,...Fahn, S. (1994). The metabolic topography of Parkinsonism. Journal of Cerebral Blood Flow and Metabolism, 14, 783-801.
40. Elsinger, C. L., Harrington, D. L., & Rao, S. M. (2006). From preparation to online control: Reappraisal of neural circuitry mediating internally generated and externally guided actions. NeuroImage, 31, 1177-1187.
41. Fahn, S. (2000). The spectrum of levodopa-induced dyskinesias. Annals of Neurology, 47, S2-S11.
42. Feigin, A., Fukuda, M., Dhawan, V., Przedborski, S., Jackson-Lewis, V., Mentis, M. J.,...Eidelberg, D. (2001). Metabolic correlates of levodopa response in Parkinson's disease. Neurology, 57, 2083-2088.
43. Feigin, A., Ghilardi, M. F., Carbon, M., Edwards, C., Fukuda, M., Dhawan, V.,...Eidelberg, D. (2003). Effects of levodopa on motor-sequence learning in Parkinson's disease. Neurology, 60, 1744-1749.
44. Feigin, A., Ghilardi, M. F., Fukuda, M., Mentis, M. J., Dhawan, V., Barnes, A.,...Eidelberg, D. (2002). Effects of levodopa infusion on motor activation responses in Parkinson's disease. Neurology, 59, 220-226.
45. François-Brosseau, F. E., Martinu, K., Strafella, A. P., Petrides, M., Simard, F., & Monchi, O. (2009). Basal ganglia and frontal involvement in self-generated and externally-triggered finger movements in the dominant and non-dominant hand. European Journal of Neuroscience, 29, 1277-1286.
46. Geday, J., Østergaard, K., Johnsen, E., & Gjedde, A. (2009). STNstimulation in Parkinson's disease restores striatal inhibition of thalamocortical projection. Human Brain Mapping, 30, 112-121.
47. Georgiou, N., Bradshaw, J. L., Iansek, R., Phillips, J. G., Mattingley, J. B., & Bradshaw, J. A. (1994). Reduction in external cues and movement sequencing in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 57, 368-370.
48. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., Jr. & Sibley, D. R. (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250, 1429-1432.
49. Glickstein, M., May, J. G., 3rd & Mercier, B. E. (1985). Corticopontine projection in the macaque: The distribution of labelled cortical cells after large injections of horseradish peroxidase in the pontine nuclei. The Journal of Comparative Neurology, 235, 343-359.
50. Glickstein, M., & Stein, J. (1991). Paradoxical movement in Parkinson's disease. Trends in neurosciences, 14, 480-482.
51. Gotham, A. M., Brown, R. G., & Marsden, C. D. (1988). 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain: A Journal of Neurology, 111, 299-321.
52. Grafton, S. T., Turner, R. S., Desmurget, M., Bakay, R., Delong, M., Vitek, J., & Crutcher, M. (2006). Normalizing motor-related brain activity: Subthalamic nucleus stimulation in Parkinson disease. Neurology, 66, 1192-1199.
53. Guehl, D., Pessiglione, M., François, C., Yelnik, J., Hirsch, E. C., Feger, J., & Tremblay, L. (2003). Tremor-related activity of neurons in the 'motor' thalamus: Changes in firing rate and pattern in the MPTP vervet model of parkinsonism. The European Journal of Neuroscience, 17, 2388-2400.
54. Hall, H., Sedvall, G., Magnusson, O., Kopp, J., Halldin, C., & Farde, L. (1994). Distribution of D1and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology, 11, 245-256.
55. Hallett, M. (1990). Clinical neurophysiology of akinesia. Revue Neurologique, 146, 585-590.
56. Hamani, C., Saint-Cyr, J. A., Fraser, J., Kaplitt, M., & Lozano, A. M. (2004). The subthalamic nucleus in the context of movement disorders. Brain: A Journal of Neurology, 127, 4-20.
57. Hashimoto, T., Elder, C. M., Okun, M. S., Patrick, S. K., & Vitek, J. L. (2003). Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. Journal of Neuroscience, 23, 1916-1923.
58. Haslinger, B., Erhard, P., Kampfe, N., Boecker, H., Rummeny, E., Schwaiger, M.,...Ceballos-Baumann, A. O. (2001). Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain: A Journal of Neurology, 124, 558-570.
59. Hauser, R. A., & Zesiewicz, T. A. (2007). Advances in the pharmacologic management of early Parkinson disease. Neurologist, 13, 126-132.
60. Helmich, R. C., Janssen, M. J., Oyen, W. J., Bloem, B. R., & Toni, I. (2011). Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor. Annals of Neurology, 69, 269-281.
61. Heman, P., Barcia, C., Gomez, A., Ros, C. M., Ros-Bernal, F., Yuste, J.E.,...Herrero, M. T. (2012). Nigral degeneration correlates with persistent activation of cerebellar Purkinje cells in MPTP-treated monkeys. Histology and Histopathology, 27, 89-94.
62. Hershey, T., Revilla, F. J., Wernle, A. R., McGee-Minnich, L., Antenor, J. V., Videen, T. O.,...Perlmutter, J. S. (2003). Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology, 61, 816-821.
63. Hilker, R., Voges, J., Ghaemi, M., Lehrke, R., Rudolf, J., Koulousakis, A.,...Heiss, W. D. (2003). Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Movement Disorders, 18, 41-48.
64. Hilker, R., Voges, J., Weisenbach, S., Kalbe, E., Burghaus, L., Ghaemi, M.,...Heiss, W. D. (2004). Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: Evidence from a FDG-PET study in advanced Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism, 24, 7-16.
65. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: onset, progression and mortality. Neurology, 17, 427-442.
66. Hornykiewicz, O. (1975). Brain monoamines and parkinsonism. National Institute on Drug Abuse Research Monograph Series, November, 13-21.
67. Hoshi, E., Tremblay, L., Feger, J., Carras, P. L., & Strick, P. L. (2005). The cerebellum communicates with the basal ganglia. Nature Neuroscience, 8, 1491-1493.
68. Huang, C., Tang, C., Feigin, A., Lesser, M., Ma, Y., Pourfar, M.,... Eidelberg, D. (2007). Changes in network activity with the progression of Parkinson's disease. Brain: A Journal of Neurology, 130, 1834-1846.
69. Hülsmann, E., Erb, M., & Grodd, W. (2003). From will to action: Sequential cerebellar contributions to voluntary movement. NeuroImage, 20, 1485-1492.
70. Ikai, Y., Takada, M., Shinonaga, Y., & Mizuno, N. (1992). Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei. Neuroscience, 51, 719-728.
71. Ikawa, M., Okazawa, H., Kudo, T., Kuriyama, M., Fujibayashi, Y., & Yoneda, M. (2011). Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET. Nuclear Medicine and Biology, 38, 945-951.
72. Jansen, K. L., Faull, R. L., Dragunow, M., & Leslie, R. A. (1991). Autoradiographic distribution of sigma receptors in human neocortex, hippocampus, basal ganglia, cerebellum, pineal and pituitary glands. Brain Research, 559, 172-177.
73. Jenkins, I. H., Fernandez, W., Playford, E. D., Lees, A. J., Frackowiak, R. S., Passingham, R. E., & Brooks, D. J. (1992). Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Annals of Neurology, 32, 749-757.
74. Jenkins, I. H., Jahanshahi, M., Jueptner, M., Passingham, R. E., & Brooks, D. J. (2000). Self-initiated versus externally triggered movements: II. The effect of movement predictability on regional cerebral blood flow. Brain: A Journal of Neurology, 123, 1216-1228.
75. Jenner, P. (2003). Oxidative stress in Parkinson's disease. Annals of Neurology, 53, S26-S38.
76. Jubault, T., Monetta, L., Strafella, A. P., Lafontaine, A. L., & Monchi, O. (2009). L-dopa medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network. PLoS One, 4, e6154.
77. Karimi, M., Golchin, N., Tabbal, S. D., Hershey, T., Videen, T. O., Wu, J.,... Perlmutter, J. S. (2008). Subthalamic nucleus stimulationinduced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain: A Journal of Neurology, 131, 2710-2719.
78. Kelly, R. M., & Strick, P. L. (2003). Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate. The Journal of Neuroscience, 23, 8432-8444.
79. Khan, T. S. (2012). Off spells and dyskinesias: Pharmacologic management of motor complications. Cleveland Clinic Journal of Medicine, 79, S8-S13.
80. Kim, S. G., Ugurbil, K., & Strick, P. L. (1994). Activation of a cerebellar output nucleus during cognitive processing. Science, 265, 949-951.
81. Kish, S. J., Shannak, K., & Hornykiewicz, O. (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. New England Journal of Medicine, 318, 876-880.
82. Kish, S. J., Shannak, K. S., Rajput, A. H., Gilbert, J. J., & Hornykiewicz, O. (1984). Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Archives of Neurology, 41, 612-614.
83. Ko, J. H., Monchi, O., Ptito, A., Bloomfield, P., Houle, S., & Strafella, A. P. (2008). Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: A TMS-[11C]raclopride PET study. European Journal of Neuroscience, 28, 2147-2155.
84. Koch, G., Brusa, L., Caltagirone, C., Peppe, A., Oliveri, M., Stanzione, P., & Centonze, D. (2005). rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease. Neurology, 65, 623-625.
85. Koch, G., Brusa, L., Carrillo, F., Lo Gerfo, E., Torriero, S., Oliveri, M.,...Stanzione, P. (2009). Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease. Neurology, 73, 113-119.
86. Kuhl, D. E., Metter, E. J., & Riege, W. H. (1984). Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method. Annals of Neurology, 15, 419-424.
87. Leiner, H. C., Leiner, A. L., & Dow, R. S. (1989). Reappraising the cerebellum: What does the hindbrain contribute to the forebrain? Behavioral Neuroscience, 103, 998-1008.
88. Lewis, M. M., Du, G., Sen, S., Kawaguchi, A., Truong, Y., Lee, S.,... Huang, X. (2011). Differential involvement of striatoand cerebellothalamo-cortical pathways in tremorand akinetic/rigid-predominant Parkinson's disease. Neuroscience, 177, 230-239.
89. Lewis, M. M., Slagle, C. G., Smith, A. B., Truong, Y., Bai, P., McKeown, M.J.,...Huang, X. (2007). Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries. Neuroscience, 147, 224-235.
90. Lozano, A. M., Lang, A. E., Levy, R., Hutchison, W., & Dostrovsky, J. (2000). Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Annals of Neurology, 47, S141-S146.
91. Lyons, K. E., & Pahwa, R. (2008). Deep brain stimulation and tremor. Neurotherapeutics, 5, 331-338.
92. MacDonald, P. A., MacDonald, A. A., Seergobin, K. N., Tamjeedi, R., Ganjavi, H., Provost, J. S., & Monchi, O. (2011). The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: Support from functional MRI. Brain: A Journal of Neurology, 134, 1447-1463.
93. MacDonald, P. A., & Monchi, O. (2011). Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: Implications for cognitive function. Parkinson's Disease, 2011, no pagination.
94. Martignoni, E., Blandini, F., Godi, L., Desideri, S., Pacchetti, C., Mancini, F., & Nappi, G. (1999). Peripheral markers of oxidative stress in Parkinson's disease. The role of L-DOPA. Free Radical Biology & Medicine, 27, 428-437.
95. Martin, W. R., Beckman, J. H., Calne, D. B., Adam, M. J., Harrop, R., Rogers, J. G.,...Pate, B. D. (1984). Cerebral glucose metabolism in Parkinson's disease. The Canadian Journal of Neurological Sciences, 11, 169-173.
96. Martinu, K., Degroot, C., Madjar, C., Strafella, A. P., & Monchi, O. (2012). Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease. European Journal of Neuroscience, 35, 572-583.
97. Matano, S. (2001). Brief communication: Proportions of the ventral half of the cerebellar dentate nucleus in humans and great apes. American Journal of Physical Anthropology, 114, 163-165.
98. Matsumoto, R. R., Hemstreet, M. K., Lai, N. L., Thurkauf, A., De Costa, B. R., Rice, K. C.,...Walker, J. M. (1990). Drug specificity of pharmacological dystonia. Pharmacology Biochemistry and Behavior, 36, 151-155.
99. Mattay, V. S., Callicott, J. H., Bertolino, A., Santha, A. K., Van Horn, J. D., Tallent KA,...Weinberger, D. R. (1998). Hemispheric control of motor function: A whole brain echo planar fMRI study. Psychiatry Research: Neuroimaging, 83, 7-22.
100. Mattay, V. S., Tessitore, A., Callicott, J. H., Bertolino, A., Goldberg, T. E., Chase, T. N.,...Weinberger, D. R. (2002). Dopaminergic modulation of cortical function in patients with Parkinson's disease. Annals of Neurology, 51, 156-164.
101. Mentis, M. J., Dhawan, V., Feigin, A., Delalot, D., Zgaljardic, D., Edwards, C., & Eidelberg, D. (2003). Early stage Parkinson's disease patients and normal volunteers: Comparative mechanisms of sequence learning. Human Brain Mapping, 20, 246-258.
102. Middleton, F. A., & Strick, P. L. (2000). Basal ganglia and cerebellar loops: Motor and cognitive circuits. Brain Research Reviews, 31, 236-250.
103. Middleton, F. A., & Strick, P. L. (2001). Cerebellar projections to the prefrontal cortex of the primate. The Journal of Neuroscience, 21, 700-712.
104. Moeller, J. R., Nakamura, T., Mentis, M. J., Dhawan, V., Spetsieres, P., Antonini, A.,...Eidelberg, D. (1999). Reproducibility of regional metabolic covariance patterns: Comparison of four populations. Journal of Nuclear Medicine, 40, 1264-1269.
105. Moeller, J. R., & Strother, S. C. (1991). A regional covariance approach to the analysis of functional patterns in positron emission tomographic data. Journal of Cerebral Blood Flow and Metabolism, 11, A121-A135.
106. Monakow, K. H., Akert, K., & Kunzle, H. (1978). Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Experimental Brain Research, 33, 395-403.
107. Monchi, O., Martinu, K., & Strafella, A. P. (2010). The contribution of neuroimaging for the study of cognitive deficits in Parkinson's disease. Clinical EEG and Neuroscience, 41, 76-81.
108. Monchi, O., Petrides, M., Doyon, J., Postuma, R. B., Worsley, K., & Dagher, A. (2004). Neural bases of set-shifting deficits in Parkinson's disease. The Journal of Neuroscience, 24, 702-710.
109. Monchi, O., Petrides, M., Mejia-Constain, B., & Strafella, A. P. (2007). Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain: A Journal of Neurology, 130, 233-244.
110. Montastruc, J. L., Rascol, O., Senard, J. M., & Rascol, A. (1994). A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: A five year follow up. Journal of Neurology, Neurosurgery & Psychiatry, 57, 1034-1038.
111. Mure, H., Hirano, S., Tang, C. C., Isaias, I. U., Antonini, A., Ma, Y.,... Eidelberg, D. (2011). Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects. NeuroImage, 54, 1244-1253.
112. Nagatsu, T., Levitt, M., & Udenfriend, S. (1964). Tyrosine hydroxylase: The initial step in norepinephrine biosynthesis. Journal of Biological Chemistry, 239, 2910-2917.
113. Nambu, A., Tokuno, H., & Takada, M. (2002). Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neuroscience Research, 43, 111-117.
114. Ng, B., Palmer, S., Abugharbieh, R., & McKeown, M. J. (2010). Focusing effects of L-dopa in Parkinson's disease. Human Brain Mapping, 31, 88-97.
115. Niethammer, M., Carbon, M., Argyelan, M., & Eidelberg, D. (2011). Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging. Neurobiology of Disease, 42, 202-209.
116. Nimura, T., Ando, T., Yamaguchi, K., Nakajima, T., Shirane, R., Itoh, M., & Tominaga, T. (2004). The role of sigma-receptors in levodopainduced dyskinesia in patients with advanced Parkinson disease: A positron emission tomography study. Journal of Neurosurgery, 100, 606-610.
117. Orioli, P. J., & Strick, P. L. (1989). Cerebellar connections with the motor cortex and the arcuate premotor area: An analysis employing retrograde transneuronal transport of WGA-HRP. The Journal of Comparative Neurology, 288, 612-626.
118. Østergaard, K., & Sunde, N. A. (2006). Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Movement Disorders, 21, 624-631.
119. Palmer, S. J., Ng, B., Abugharbieh, R., Eigenraam, L., & McKeown, M. J. (2009). Motor reserve and novel area recruitment: Amplitude and spatial characteristics of compensation in Parkinson's disease. European Journal of Neuroscience, 29, 2187-2196.
120. Payoux, P., Remy, P., Damier, P., Miloudi, M., Loubinoux, I., Pidoux, B.,... Agid, Y. (2004). Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Archives of Neurology, 61, 1307-1313.
121. Pedrosa, D. J., Reck, C., Florin, E., Pauls, K. A., Maarouf, M., Wojtecki, L.,...Timmermann, L. (2012). Essential tremor and tremor in Parkinson's disease are associated with distinct 'tremor clusters' in the ventral thalamus. Experimental Neurology, 237, 445-443.
122. Piccini, P., Weeks, R. A., & Brooks, D. J. (1997). Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Annals of Neurology, 42, 720-726.
123. Pifl, C., Schingnitz, G., & Hornykiewicz, O. (1991). Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience, 44, 591-605.
124. Playford, E. D., Jenkins, I. H., Passingham, R. E., Nutt, J., Frackowiak, R. S., & Brooks, D. J. (1992). Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study. Annals of Neurology, 32, 151-161.
125. Purzner, J., Paradiso, G. O., Cunic, D., Saint-Cyr, J. A., Hoque, T., Lozano, A. M., Lang, A. E., Moro, E., Hodaie, M., Mazzella, F., & Chen, R. (2007). Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humans. The Journal of Neuroscience, 27, 6029-6036.
126. Quinn, N. (1995). Drug treatment of Parkinson's disease. BMJ: British Medical Journal, 310, 575-579.
127. Ramnani, N. (2006). The primate cortico-cerebellar system: Anatomy and function. Nature Reviews Neuroscience, 7, 511-522.
128. Ramnani, N., Behrens, T. E., Johansen-Berg, H., Richter, M. C., Pinsk, M. A., Andersson, J. L.,...Matthews, P. M. (2006). The evolution of prefrontal inputs to the cortico-pontine system: Diffusion imaging evidence from Macaque monkeys and humans. Cerebral Cortex, 16, 811-818.
129. Rao, S. M., Harrington, D. L., Haaland, K. Y., Bobholz, J. A., Cox, R. W., & Binder, J. R. (1997). Distributed neural systems underlying the timing of movements. The Journal of Neuroscience, 17, 5528-5535.
130. Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000). A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. New England Journal of Medicine, 342, 1484-1491.
131. Rascol, O., Sabatini, U., Fabre, N., Brefel, C., Loubinoux, I., Celsis, P.,...Chollet, F. (1997). The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic Parkinsonian patients. Brain: A Journal of Neurology, 120, 103-110.
132. Rinne, U. K. (1989). Lisuride, a dopamine agonist in the treatment of early Parkinson's disease. Neurology, 39, 336-339.
133. Rodriguez-Oroz, M. C., Zamarbide, I., Guridi, J., Palmero, M. R., & Obeso, J. A. (2004). Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: Double blind and open label evaluation. Journal of Neurology, Neurosurgery & Psychiatry, 75, 1382-1385.
134. Romo, R., Scarnati, E., & Schultz, W. (1992). Role of primate basal ganglia and frontal cortex in the internal generation of movements: II. Movement-related activity in the anterior striatum. Experimental Brain Research, 91, 385-395.
135. Romo, R., & Schultz, W. (1992). Role of primate basal ganglia and frontal cortex in the internal generation of movements: III. Neuronal activity in the supplementary motor area. Experimental Brain Research, 91, 396-407.
136. Sabatini, U., Boulanouar, K., Fabre, N., Martin, F., Carel, C., Colonnese, C.,...Rascol, O. (2000). Cortical motor reorganization in akinetic patients with Parkinson's disease: A functional MRI study. Brain: A Journal of Neurology, 123, 394-403.
137. Sabens, E. A., Distler, A. M., & Mieyal, J. J. (2010). Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: Implications for therapy of Parkinson's disease. Biochemistry, 49, 2715-2724.
138. Sadnicka, A., Hoffland, B. S., Bhatia, K. P., van de Warrenburg, B. P., & Edwards, M. J. (2012). The cerebellum in dystonia: Help or hindrance? Clinical Neurophysiology, 123, 65-70.
139. Schapiro, M. B., Pietrini, P., Grady, C. L., Ball, M. J., DeCarli, C., Kumar, A.,...Haxby, J. V. (1993). Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry, 56, 859-864.
140. Schmahmann, J. D., & Pandya, D. N. (1995). Prefrontal cortex projections to the basilar pons in rhesus monkey: Implications for the cerebellar contribution to higher function. Neuroscience Letters, 199, 175-178.
141. Schweighofer, N., Doya, K., & Kuroda, S. (2004). Cerebellar aminergic neuromodulation: Towards a functional understanding. Brain Research Reviews, 44, 103-116.
142. Seidel, K., Siswanto, S., Brunt, E. R., den Dunnen, W., Korf, H. W., & Rub, U. (2012). Brain pathology of spinocerebellar ataxias. Acta Neuropathologica, 124, 1-21.
143. Sen, S., Kawaguchi, A., Truong, Y., Lewis, M. M., & Huang, X. (2010). Dynamic changes in cerebello-thalamo-cortical motor circuitry during progression of Parkinson's disease. Neuroscience, 166, 712-719.
144. Shin, J. C., & Ivry, R. B. (2003). Spatial and temporal sequence learning in patients with Parkinson's disease or cerebellar lesions. Journal of Cognitive Neuroscience, 15, 1232-1243.
145. Sokoloff, P., Giros, B., Martres, M. P., Bouthenet, M. L., & Schwartz, J. C. (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 347, 146-151.
146. Steeves, T. D., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T.,... Strafella, A. P. (2009). Increased striatal dopamine release in Parkinsonian patients with pathological gambling: A[11C]raclopride PET study. Brain: A Journal of Neurology, 132, 1376-1385.
147. Stein, J. F., & Aziz, T. Z. (1999). Does imbalance between basal ganglia and cerebellar outputs cause movement disorders? Current Opinion in Neurology, 12, 667-669.
148. Stevenson, J. K., Oishi, M. M., Farajian, S., Cretu, E., Ty, E., & McKeown, M. J. (2011). Response to sensory uncertainty in Parkinson's disease: A marker of cerebellar dysfunction? European Journal of Neuroscience, 33, 298-305.
149. Stoodley, C. J., & Schmahmann, J. D. (2009). Functional topography in the human cerebellum: A meta-analysis of neuroimaging studies. NeuroImage, 44, 489-501.
150. Strick, P. L., Dum, R. P., Fiez J. A. (2009). Cerebellum and nonmotor function. Annual Review of Neuroscience, 32, 413-434.
151. Su, P. C., Ma, Y., Fukuda, M., Mentis, M. J., Tseng, H. M., Yen, R. F.,... Eidelberg, D. (2001). Metabolic changes following subthalamotomy for advanced Parkinson's disease. Annals of Neurology, 50, 514-520.
152. Szot, P. (2012). Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: Possible role of the noradrenergic nervous system. Epilepsia, 53, 61-66.
153. Taniwaki, T., Okayama, A., Yoshiura, T., Nakamura, Y., Goto, Y., Kira, J., & Tobimatsu, S. (2003). Reappraisal of the motor role of basal ganglia: A functional magnetic resonance image study. The Journal of Neuroscience, 23, 3432-3438.
154. Taylor, A. E., & Saint-Cyr, J. A. (1995). The neuropsychology of Parkinson's disease. Brain and Cognition, 28, 281-296.
155. Trošt, M., Su, S., Su, P., Yen, R. F., Tseng, H. M., Barnes, A.,... Eidelberg, D. (2006). Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. NeuroImage, 31, 301-307.
156. Turner, R. S., Grafton, S. T., McIntosh, A. R., DeLong, M. R., & Hoffman, J. M. (2003). The functional anatomy of Parkinsonian bradykinesia. NeuroImage, 19, 163-179.
157. Volkmann, J. (2004). Deep brain stimulation for the treatment of Parkinson's disease. Journal of Clinical Neurophysiology: Official publication of the American Electroencephalographic Society, 21, 6-17.
158. Wichmann, T., & Delong, M. R. (2011). Deep-brain stimulation for basal ganglia disorders. Basal Ganglia, 1, 65-77.
159. Wider, C., Pollo, C., Bloch, J., Burkhard, P. R., & Vingerhoets, F. J. (2008). Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism & Related Disorders, 14, 114-119.
160. Winterer, G. (2006). Cortical microcircuits in schizophrenia: The dopamine hypothesis revisited. Pharmacopsychiatry, 39, S68-S71.
161. Wu, T., & Hallett, M. (2005). A functional MRI study of automatic movements in patients with Parkinson's disease. Brain: A Journal of Neurology, 128, 2250-2259.
162. Wu, T., Wang, L., Hallett, M., Chen, Y., Li, K., & Chan, P. (2011). Effective connectivity of brain networks during self-initiated movement in Parkinson's disease. NeuroImage, 55, 204-215.
163. Yu, H., Sternad, D., Corcos, D. M., & Vaillancourt, D. E. (2007). Role of hyperactive cerebellum and motor cortex in Parkinson's disease. NeuroImage, 35, 222-233.
164. Yung, K. K., Smith, A. D., Levey, A. I., & Bolam, J. P. (1996). Synaptic connections between spiny neurons of the direct and indirect pathways in the neostriatum of the rat: Evidence from dopamine receptor and neuropeptide immunostaining. European Journal of Neuroscience, 8, 861-869.